Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Genital Warts (Condylomata Acuminata), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Genital Warts (Condylomata Acuminata) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Genital Warts (Condylomata Acuminata) Overview
  3. Therapeutics Development
  4. Pipeline Products for Genital Warts (Condylomata Acuminata) - Overview
  5. Pipeline Products for Genital Warts (Condylomata Acuminata) - Comparative Analysis
  6. Genital Warts (Condylomata Acuminata) - Therapeutics under Development by Companies
  7. Genital Warts (Condylomata Acuminata) - Therapeutics under Investigation by Universities/Institutes
  8. Genital Warts (Condylomata Acuminata) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Genital Warts (Condylomata Acuminata) - Products under Development by Companies
  13. Genital Warts (Condylomata Acuminata) - Products under Investigation by Universities/Institutes
  14. Genital Warts (Condylomata Acuminata) - Companies Involved in Therapeutics Development
  • Agilvax, Inc.
  • Aviragen Therapeutics, Inc.
  • Biogenomics Limited
  • BioMAS Ltd.
  • Foamix Pharmaceuticals Ltd.
  • G&E Herbal Biotechnology Co., Ltd.
  • Helix BioPharma Corp.
  • Laboratories Ojer Pharma S.L.
  • LEO Pharma A/S
  • Novan, Inc.
  • Novartis AG
  • Tamir Biotechnology, Inc.
  • Zydus Cadila Healthcare Limited

For more information visit http://www.researchandmarkets.com/research/pclmxh/genital_warts

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Dermatological Drugs, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Dermatological Drugs, Sexual and Reproductive Health Drugs